Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

RAPT Therapeutics (RAPT) Gross Profit: 2020-2022

Historic Gross Profit for Therapeutics (RAPT) over the last 2 years, with Jun 2022 value amounting to $886,000.

  • Therapeutics' Gross Profit rose 1.96% to $886,000 in Q2 2022 from the same period last year, while for Jun 2022 it was $3.2 million, marking a year-over-year decrease of 33.98%. This contributed to the annual value of $1.5 million for FY2022, which is 59.95% down from last year.
  • As of Q2 2022, Therapeutics' Gross Profit stood at $886,000, which was up 38.22% from $641,000 recorded in Q1 2022.
  • Therapeutics' 5-year Gross Profit high stood at $1.5 million for Q3 2020, and its period low was $641,000 during Q1 2022.
  • In the last 3 years, Therapeutics' Gross Profit had a median value of $950,500 in 2020 and averaged $1.0 million.
  • Its Gross Profit has fluctuated over the past 5 years, first soared by 30.70% in 2021, then tumbled by 47.55% in 2022.
  • Therapeutics' Gross Profit (Quarterly) stood at $1.3 million in 2020, then crashed by 41.94% to $756,000 in 2021, then climbed by 1.96% to $886,000 in 2022.
  • Its Gross Profit was $886,000 in Q2 2022, compared to $641,000 in Q1 2022 and $756,000 in Q4 2021.